The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Adenosine
Adenosine · ADENOSINE 3 mg/mL · Injection · Intravenous · ProPharma Distribution
NDC 84549-0318-02 · 2 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- ProPharma DistributionUnited Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA206778
- TE code
- AP
- Approval date
- Feb 16, 2018
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Adenosine (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Mylan Institutional LLC | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| ProPharma Distribution | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Sagent Pharmaceuticals | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Gland Pharma Limited | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | ADENOSINE 3 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Adenosine — NDC 84549-0318-02," retrieved September 3, 2026, https://drugdashboards.com/drug/84549031802.
Free to cite with attribution — see how the data is put together.